veristat Infographics

  1. FDA Expedited Programs – What You Need To Know 6/4/2026

    Explore FDA expedited programs and learn how Fast Track, Breakthrough Therapy, RMAT, Priority Review, and more can help accelerate development and bring therapies to patients sooner.

  2. Four Pillars Of Success In Neurology Clinical Trials 5/27/2026

    Neurology clinical trials face unique challenges, and here we explore the four critical pillars for improving neurology study success.

  3. A Practical Guide For Managing Multiple Global Regulatory Pathways 5/27/2026

    Global submissions are getting faster—and more complex. Explore a 7-step framework for aligning FDA and EMA pathways to reduce risk, duplication, and regulatory delays.

  4. Does Your CRO Excel In Oncology Regulatory Publishing? 5/27/2026

    Oncology approvals move fast. Learn how experienced CRO publishing teams help sponsors navigate RTOR, Project Orbis, and complex global submissions with confidence.

  5. Accelerating Patient-Centric Trials With A Sponsor's Checklist 8/12/2025

    Effective trial success in today’s complex research environment requires early planning. This checklist will help you to strengthen planning, elevate patient engagement, and drive submission success.

  6. How Does RWE Impact Clinical Trials? 4/10/2025

    Explore the growing impact of Real-World Evidence (RWE) on clinical trials, particularly in rare disease research.

  7. FDA Guidance On The Use Of DMCs In Clinical Trials 9/4/2024

    Gain an overview of FDA guidance on the use of Data Monitoring Committees (DMCs) in clinical trials and their critical role in safeguarding patient safety and ensuring unbiased decision-making.

  8. Understanding Data Monitoring Committees 9/4/2024

    Data Monitoring Committees (DMCs) provide independent oversight in clinical trials. Discover how expertise in organizing DMCs strengthens trial integrity through rigorous risk-benefit assessments.

  9. Successfully Prepare Structure-Data Files For Regulatory Submissions 8/31/2023

    Review the guidelines for creating an SD file and the updated process for submitting to the FDA's KASA review program to best prepare regulatory submissions.

  10. FDA Meeting Types With CDER And CBER For Biosimilar Products 6/7/2023

    Get a summary of the different types of meetings under BsUFA for biosimilar products, including their applicability, examples, and the timing parameters of each meeting type.